We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$37.8B
AUM Growth
+$3.94B
Cap. Flow
+$1.54B
Cap. Flow %
4.08%
Top 10 Hldgs %
22%
Holding
1,437
New
65
Increased
570
Reduced
395
Closed
99

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$73.7M
2
LIN icon
Linde
LIN
+$68.9M
3
SHW icon
Sherwin-Williams
SHW
+$52.4M
4
MDT icon
Medtronic
MDT
+$52.2M
5
CRM icon
Salesforce
CRM
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Healthcare 19.83%
3 Financials 11.79%
4 Industrials 9.64%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTL
1251
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$162K ﹤0.01%
26,983
EXPO icon
1252
Exponent
EXPO
$3.26B
$160K ﹤0.01%
1,603
SAFE
1253
DELISTED
Safehold Inc.
SAFE
$158K ﹤0.01%
5,407
+1,142
+27% +$32.5K
CHCT
1254
Community Healthcare Trust
CHCT
$435M
$156K ﹤0.01%
4,338
HOOD icon
1255
Robinhood
HOOD
$84.1B
$156K ﹤0.01%
19,756
+7,763
+65% +$76.1K
TAL icon
1256
TAL Education Group
TAL
$6.76B
$156K ﹤0.01%
22,477
-326
-1% -$1.81K
DICE
1257
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$156K ﹤0.01%
+5,000
New +$163K
FLNG icon
1258
FLEX LNG
FLNG
$1.58B
$154K ﹤0.01%
4,698
-1,286
-21% -$43K
MANH icon
1259
Manhattan Associates
MANH
$11.5B
$154K ﹤0.01%
1,265
PTGX icon
1260
Protagonist Therapeutics
PTGX
$9.67B
$154K ﹤0.01%
15,800
NRIX icon
1261
Nurix Therapeutics
NRIX
$2.71B
$153K ﹤0.01%
14,000
PMVP icon
1262
PMV Pharmaceuticals
PMVP
$69.9M
$152K ﹤0.01%
17,600
MGY icon
1263
Magnolia Oil & Gas
MGY
$6.2B
$148K ﹤0.01%
+6,374
New +$155K
IGMS
1264
DELISTED
IGM Biosciences
IGMS
$147K ﹤0.01%
9,100
ASML icon
1265
ASML
ASML
$686B
$145K ﹤0.01%
+270
New +$141K
S icon
1266
SentinelOne
S
$7.71B
$144K ﹤0.01%
10,000
KZR
1267
DELISTED
Kezar Life Sciences
KZR
$143K ﹤0.01%
2,000
UHT
1268
Universal Health Realty Income Trust
UHT
$574M
$141K ﹤0.01%
2,921
RKLB icon
1269
Rocket Lab Corp
RKLB
$48.5B
$139K ﹤0.01%
+37,578
New +$164K
OPI
1270
DELISTED
Office Properties Income Trust
OPI
$132K ﹤0.01%
9,723
WEX icon
1271
WEX
WEX
$6.46B
$129K ﹤0.01%
796
-88
-10% -$13.7K
EVBG
1272
DELISTED
Everbridge, Inc. Common Stock
EVBG
$129K ﹤0.01%
4,610
MSBI icon
1273
Midland States Bancorp
MSBI
$695M
$128K ﹤0.01%
4,790
GLUE icon
1274
Monte Rosa Therapeutics
GLUE
$1.35B
$121K ﹤0.01%
16,500
APPS icon
1275
Digital Turbine
APPS
$1.63B
$120K ﹤0.01%
7,937
-17,636
-69% -$271K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2022 Portfolio in Review

As of Q4 2022, DekaBank Deutsche Girozentrale held 1,437 positions worth $37.8B, up 12% from $33.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.54B of net new capital in Q4 2022, opening 65 new positions and adding to 570 existing holdings. Its largest new stake was Wolfspeed: 120,839 shares worth $8.28M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $73.7M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2022 buy was Wolfspeed: 120,839 shares worth $8.28M.
  • DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q4 2022, an estimated $186M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $73.7M.
  • DekaBank Deutsche Girozentrale fully exited Duke Realty Corp. in Q4 2022, selling an estimated $16.3M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 22% of its $37.8B portfolio in Q4 2022.
  • DekaBank Deutsche Girozentrale opened 65 new positions and closed 99 in Q4 2022.
  • DekaBank Deutsche Girozentrale's portfolio value rose 12% quarter-over-quarter to $37.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.